To assess the impact of BRD7 on anti-tumor immunity in NPC, we examined the infiltration of CD8+ T lymphocytes in tumor tissues (Figure 6G, Figure S5B). The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.